Croda PLC resumes its descent as Barclays cuts its rating to ‘underweight’ from
Croda shares jumped on Tuesday on the back of an agreement with Pfizer to supply excipients, which are substances…
Read More...
Read More...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.
We respect your privacy and take protecting it seriously
Recover your password.
A password will be e-mailed to you.